REGENXBIO to Participate in Upcoming Investor Conferences

Rhea-AI Summary

REGENXBIO Inc. (Nasdaq: RGNX) announced its participation in two upcoming investor conferences. The Bank of America Securities 2022 Healthcare Conference will take place on May 10, 2022, at the Encore Hotel in Las Vegas, with a presentation scheduled for 4:00 p.m. PT. The UBS Global Healthcare Conference 2022 is set for May 24, 2022, at Lotte New York Palace, with a presentation at 10:45 a.m. ET. Webcasts of both events will be available on the REGENXBIO website for approximately 30 days following their presentations.

ROCKVILLE, Md., May 4, 2022 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following upcoming investor conferences:

Bank of America Securities 2022 Healthcare Conference
Date: Tuesday, May 10, 2022
Location: Encore Hotel, Las Vegas, NV
Presentation: Tuesday, May 10, 2022 at 4:00 p.m. PT

UBS Global Healthcare Conference 2022
Date: Tuesday, May 24, 2022
Location: Lotte New York Palace, New York, NY
Presentation: Tuesday, May 24, 2022 at 10:45 a.m. ET

A webcast of both presentations can be accessed in the Investors section of REGENXBIO's website at www.regenxbio.com. An archived replay of the webcast will be available in the Investors section of REGENXBIO's website for approximately 30 days following the presentation.

About REGENXBIO Inc.

REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas.

Contacts:

Dana Cormack
Corporate Communications
dcormack@regenxbio.com 

Investors:
Chris Brinzey, ICR Westwicke
339-970-2843
chris.brinzey@westwicke.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-301539404.html

SOURCE REGENXBIO Inc.

FAQ

What investor conferences will REGENXBIO participate in May 2022?

REGENXBIO will participate in the Bank of America Securities Healthcare Conference on May 10, 2022, and the UBS Global Healthcare Conference on May 24, 2022.

When is REGENXBIO's presentation at the Bank of America Securities Healthcare Conference?

REGENXBIO's presentation at the Bank of America Securities Healthcare Conference is on May 10, 2022, at 4:00 p.m. PT.

Where will the UBS Global Healthcare Conference 2022 be held?

The UBS Global Healthcare Conference 2022 will be held at Lotte New York Palace in New York, NY.

What time will REGENXBIO present at the UBS Global Healthcare Conference?

REGENXBIO is scheduled to present at the UBS Global Healthcare Conference on May 24, 2022, at 10:45 a.m. ET.

How can I access REGENXBIO's conference presentations?

Webcasts of both conference presentations will be available in the Investors section of REGENXBIO's website for approximately 30 days after the events.